References
- 1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-49. DOI: 10.3322/caac.2166010.3322/caac.2166033538338
- 2. Burguin A, Diorio C, Durocher F. Breast Cancer Treatments: Updates and New Challenges. J Pers Med. 2021 Aug 19;11(8):808. DOI: 10.3390/jpm1108080810.3390/jpm11080808839913034442452
- 3. Yun CW, Kim HJ, Lim JH, Lee SH. Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy. Cells. 2019 Dec 24;9(1):60. DOI: 10.3390/cells901006010.3390/cells9010060701719931878360
- 4. Licchesi JD, Van Neste L, Tiwari VK, Cope L, Lin X, Baylin SB, et al. Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc. Oncogene. 2010 Nov;29(44):5923-34. DOI: 10.1038/onc.2010.32210.1038/onc.2010.322323012920697356
- 5. Mahoney SE, Yao Z, Keyes CC, Tapscott SJ, Diede SJ. Genome-wide DNA methylation studies suggest distinct DNA methylation patterns in pediatric embryonal and alveolar rhabdomyosarcomas. Epigenetics. 2012 Apr;7(4):400-8. DOI: 10.4161/epi.1946310.4161/epi.19463336882222419069
- 6. Alholle A, Brini AT, Gharanei S, Vaiyapuri S, Arrigoni E, Dallol A, et al. Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma. Epigenetics. 2013 Nov;8(11):1198-204. DOI: 10.4161/epi.2626610.4161/epi.2626624005033
- 7. Pencheva N, Tran H, Buss C, Huh D, Drobnjak M, Busam K, et al. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell. 2012 Nov;151(5):1068-82. DOI: 10.1016/j.cell.2012.10.02810.1016/j.cell.2012.10.028375311523142051
- 8. Pinner KD, Wales CT, Gristock RA, Vo HT, So N, Jacobs AT. Flavokawains A and B from kava (Piper methysticum) activate heat shock and antioxidant responses and protect against hydrogen peroxide-induced cell death in HepG2 hepatocytes. Pharm Biol. 2016 Sep;54(9):1503-12. DOI: 10.3109/13880209.2015.110710410.3109/13880209.2015.1107104504034626789234
- 9. Zoppino FCM, Guerrero-Gimenez ME, Castro GN, Ciocca DR. Comprehensive transcriptomic analysis of heat shock proteins in the molecular subtypes of human breast cancer. BMC Cancer. 2018 Jun;18(1):700. DOI: 10.1186/s12885-018-4621-110.1186/s12885-018-4621-1602270729954368
- 10. Buttacavoli M, Di Cara G, D’Amico C, Geraci F, Pucci-Minafra I, Feo S, et al. Prognostic and Functional Significant of Heat Shock Proteins (HSPs) in Breast Cancer Unveiled by Multi-Omics Approaches. Biology (Basel). 2021 Mar;10(3):247. DOI: 10.3390/biology1003024710.3390/biology10030247800470633810095
- 11. Klimczak M, Biecek P, Zylicz A, Zylicz M. Heat shock proteins create a signature to predict the clinical outcome in breast cancer. Sci Rep. 2019 May;9(1):7507. DOI: 10.1038/s41598-019-43556-110.1038/s41598-019-43556-1652524931101846
- 12. Lebok P, von Hassel A, Meiners J, Hube-Magg C, Simon R, Höflmayer D, et al. Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer. Aging (Albany NY). 2019 Sep;11(18):7796-804. DOI: 10.18632/aging.10228710.18632/aging.102287678199231533087
- 13. Jézéquel P, Campone M, Gouraud W, Guérin-Charbonnel C, Leux C, Ricolleau G, et al. bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer. Breast Cancer Res Treat. 2012 Feb;131(3):765-75. DOI: 10.1007/s10549-011-1457-710.1007/s10549-011-1457-721452023
- 14. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009 Mar;27(8):1160-7. DOI: 10.1200/JCO.2008.18.137010.1200/JCO.2008.18.1370266782019204204
- 15. Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK, et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017 Aug;19(8):649-658. DOI: 10.1016/j. neo.2017.05.002
- 16. Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J, et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res. 2017 Jan;45(D1):D777-D783. DOI: 10.1093/nar/gkw112110.1093/nar/gkw1121521058327899578
- 17. Romero-Garcia S, Prado-Garcia H, Carlos-Reyes A. Role of DNA Methylation in the Resistance to Therapy in Solid Tumors. Front Oncol. 2020 Aug 7;10:1152. DOI: 10.3389/fonc.2020.0115210.3389/fonc.2020.01152742672832850327
- 18. Dreos R, Ambrosini G, Périer RC, Bucher P. The Eukaryotic Promoter Database: expansion of EPDnew and new promoter analysis tools. Nucleic Acids Res. 2015 Jan;43(Database issue):D92-6. DOI: 10.1093/nar/gku111110.1093/nar/gku1111438392825378343
- 19. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res. 2002 Jun;12(6):996-1006. DOI: 10.1101/gr.22910210.1101/gr.22910218660412045153
- 20. Sun Z, Asmann YW, Kalari KR, Bot B, Eckel-Passow JE, Baker TR, et al. Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing. PLoS One. 2011 Feb;6(2):e17490. DOI: 10.1371/journal.pone.001749010.1371/journal.pone.0017490304545121364760